Net Worth Advisory Group’s Veracyte VCYT Stock Holding History

Net Worth Advisory Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,416	Closed	-$270K	–	477
2025 Q4	$270K	Buy	6,416 +7	+0.1%	+$282	0.05%	358
2025 Q3	$220K	Buy	+6,409	New	+$184K	0.06%	368
2025 Q1	–	Sell	-6,447	Closed	-$255K	–	417
2024 Q4	$255K	Sell	6,447 -208	-3%	-$7.88K	0.08%	294
2024 Q3	$227K	Buy	+6,655	New	+$187K	0.07%	348

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Net Worth Advisory Group's VCYT Position: Q1 2026 in Review

Net Worth Advisory Group sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 6,416 shares — an estimated $270K sold.

Net Worth Advisory Group first reported a position in VCYT in Q3 2024 and held it in 4 quarters. The position peaked at $270K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Net Worth Advisory Group reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
Net Worth Advisory Group sold 6,416 Veracyte shares in Q1 2026, an estimated $270K.
Net Worth Advisory Group first reported a position in Veracyte in Q3 2024 and held it in 4 quarters.
Net Worth Advisory Group's Veracyte position peaked at $270K in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Net Worth Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.